BioSpace News Archive

Deals

Quest Analytics Acquires BetterDoctor to Create First Health Plan Platform to Ensure Network Adequacy, Provider Data Accuracy and Improved Member Experience

Quest Analytics announced that it has acquired BetterDoctor

June 18, 2018
·
4 min read
Drug Development

BioLineRx Presents New Overall Survival Data From Phase 2a Study for BL-8040 in r/r AML Patients

Data presented at EHA shows significantly improved overall survival compared to historical data

June 18, 2018
·
6 min read
Business

Ionis Pharmaceuticals Appoints Damien McDevitt as Chief Business Officer

Ionis Pharmaceuticals, Inc. announced that Damien McDevitt, Ph.D. has joined the company as chief business officer.

June 18, 2018
·
5 min read
Bruker Introduces ParaVision® 360 Preclinical Imaging Software and AVANCE® NEO Systems with Advanced Multi-Receive Architecture for MRI

At the International Society of Magnetic Resonance in Medicine Conference (www.ismrm.org), Bruker announced the launch of the next version of its preclinical imaging software, ParaVision 360.

June 18, 2018
·
3 min read
Business

Alkahest, Inc. Announces Key Appointment

Michael Byrnes joins Alkahest as Chief Financial Officer

June 18, 2018
·
2 min read
Drug Development

Protagonist Announces Phase 1 and Pre-clinical Data on Hepcidin Mimetic PTG-300 Presented at European Hematology Association Annual Meeting

Protagonist Therapeutics, Inc. announced that results of a Phase 1 study in healthy volunteers and supportive pre-clinical data for the Company’s novel injectable hepcidin mimetic

June 18, 2018
·
7 min read
Drug Development

Acorda to Present Data for INBRIJA™ (levodopa inhalation powder) at 2nd Pan American Parkinson’s Disease and Movement Disorders Congress

Acorda Therapeutics, Inc.will present four encore INBRIJA posters at the upcoming 2nd Pan American Parkinson’s Disease and Movement Disorders Congress.

June 18, 2018
·
6 min read
Bio NC

Agile Sciences-Breaking the Cycle of Antibiotic Resistance

Agile Sciences has developed a proprietary portfolio of small molecules of the 2-Aminoamidazole family (2-AI) that breaks the cycle of antibiotic resistance through a novel mode of action.

June 18, 2018
·
1 min read
Drug Development

Gamida Cell to Present Preliminary Data from Ongoing Phase I NAM-NK Study at AACR International Meeting on Advances in Malignant Lymphoma

Gamida Cell announced that preliminary data from an ongoing phase I study from the nicotinamide-based natural killer cell expansion, or NAM-NK, program will be presented during the Inaugural AACR International Meeting on Advances in Malignant Lymphoma

June 18, 2018
·
2 min read
LG Chem Hosts Global Innovation Contest 2018 (GIC 2018) “Finding Innovations to Change the World”

LG Chem is exploring innovative technologies that will change the world.

June 18, 2018
·
2 min read